Pfizer PFE Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pfizer's deferred tax assets and other non-current assets?
- Pfizer (PFE) reported deferred tax assets and other non-current assets of $9.83B in Q1 2026.
- How has Pfizer's deferred tax assets and other non-current assets changed year-over-year?
- Pfizer's deferred tax assets and other non-current assets decreased by 0.1% year-over-year, from $9.85B to $9.83B.
- What is the long-term trend for Pfizer's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Pfizer's deferred tax assets and other non-current assets has grown at a 14.6% compound annual growth rate (CAGR), from $4.88B to $9.63B.